Bookmark and Share
BioAssay Select:

Show Data: Show Clear
Result Display Option
Group Results By:
Compound Duplicate Test Option:
Show Data Table: Concise Complete.

   AID: 624082
Late stage assay provider results from the probe development efforts to identify inhibitors of VIM-2 metallo-beta-lactamase (nonselective): Growth inhibition of clinically relevant New Delhi metallo-beta-lactamase-1 (NDM-1)-transformed K. pneumoniae (BAA-2146) in the presence of imipenem (synergy)Data Source: The Scripps Research Institute Molecular Screening Center (NDM-1-KPNEUMONIAE_INH_ABS_0384_SYNERGY MDCSRUN BAA-2146)

Select BioAssay Results:
  Summary Results
Activity Outcome:
MIC [4 fold reduction]*Value Range
50 :: 100
From To
BioAssay Result Version
BioAssay Data Source
* Activity Concentration.

  Other Experimental Results

Contributed Cross References
BioAssay Data Source Links

  Additional Results Filter


Other Filters:

   Substance Filter

   Compound Filter


   Select Other BioAssays

Show Data: Show Clear

PageFrom: